A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People
Status:
Not yet recruiting
Trial end date:
2023-03-16
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to learn if the study medicine (called PF-07817883) is
safe and how it goes in and out of the body in healthy people. PF-07817883 is for the
potential treatment of COVID-19. Participants will take PF-07817883 by mouth up to 2 times a
day. This study may also evaluate how much PF-07817883 gets into the body when taken as pill.
We may study if people's diets can affect this study medicine. We may also examine how
PF-07817883 is processed and removed by the human body. Finally, we may look into if
PF-07817883 has potential to interact with midazolam.